Annexon Files Definitive Proxy Statement for 2025 Annual Meeting
Ticker: ANNX · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1528115
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Annexon's proxy statement is out for the June 5th meeting - vote for directors!
AI Summary
Annexon, Inc. filed its definitive proxy statement on April 23, 2025, for its annual meeting on June 5, 2025. The filing concerns the election of directors and other corporate governance matters. The company is based in Brisbane, California, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides shareholders with crucial information regarding the company's leadership and governance, enabling them to make informed voting decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating any immediate financial or operational distress.
Key Numbers
- 20250605 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
Key Players & Entities
- Annexon, Inc. (company) — Registrant
- 20250423 (date) — Filing Date
- 20250605 (date) — Annual Meeting Date
- Brisbane, CA (location) — Company Headquarters
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting on June 5, 2025, including details for the election of directors and other corporate governance matters.
When was the definitive proxy statement filed?
The definitive proxy statement was filed on April 23, 2025.
Where is Annexon, Inc. headquartered?
Annexon, Inc. is headquartered in Brisbane, California.
What is Annexon, Inc.'s Standard Industrial Classification (SIC) code?
Annexon, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing fee status for this document?
The filing indicates that no fee was required for this filing.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding Annexon, Inc. (ANNX).